Article
Reconstructing the evolutionary history of multiple myeloma.
Best practice & research. Clinical haematology - 1 Mar 2020
Maura Francesco, Rustad Even H, Boyle Eileen M, Morgan Gareth J
Abstract excerpt
Multiple myeloma is the second most common lymphoproliferative disorder, characterized by aberrant expansion of monoclonal plasma cells. In the last years, thanks to novel next generation sequencing technologies, multiple myeloma has emerged as one of the most complex hematological cancers, shaped over time by the activity of multiple mutational processes and by the acquisition of key driver events. In this...
Topics
- Aneuploidy
- Antineoplastic Combined Chemotherapy Protocols
- Chromothripsis
- Evolution, Molecular
- Genome, Human
- High-Throughput Nucleotide Sequencing
- Humans
- Multiple Myeloma
- Mutation
- Neoplasm, Residual
- Plasma Cells
- Recurrence
- Survival Analysis
- Time Factors
- Whole Genome Sequencing
